Viewpoint on the 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias.

IF 2 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Journal of Cardiovascular Medicine Pub Date : 2025-09-01 Epub Date: 2025-09-19 DOI:10.2459/JCM.0000000000001777

Kapka Miteva, Aliki Buhayer, Cédric Follonier, François Mach

引用次数: 0

Abstract

The 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias incorporates significant new evidence from major randomized controlled trials, as well as relevant systematic reviews and meta-analyses published since 2019 and up until 31 March 2025. The Update targets specific areas in which new data on prognostics models, diagnostic accuracy studies and therapeutics, including assessment of risk-benefit ratios, could immediately influence clinical practice, providing revised or new recommendations.

查看原文本刊更多论文

关于2019年ESC/EAS血脂异常管理指南2025年重点更新的观点

2019年ESC/EAS血脂异常管理指南2025年重点更新纳入了来自主要随机对照试验的重要新证据，以及自2019年以来至2025年3月31日发表的相关系统评价和荟萃分析。《更新》针对一些特定领域，在这些领域，关于预后模型、诊断准确性研究和治疗方法（包括风险-效益比评估）的新数据可能会立即影响临床实践，并提供修订或新的建议。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Cardiovascular Medicine 医学-心血管系统

CiteScore

3.90

自引率

26.70%

发文量

189

审稿时长

6-12 weeks

期刊介绍： Journal of Cardiovascular Medicine is a monthly publication of the Italian Federation of Cardiology. It publishes original research articles, epidemiological studies, new methodological clinical approaches, case reports, design and goals of clinical trials, review articles, points of view, editorials and Images in cardiovascular medicine. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.